INO

VGX-3100

Precancerous Cervical Dysplasia (HSIL)

Stage (next event)

Expected Date

Phase 3 Data

H1 2021

Catalyst Info & Data Links

TITLE: VGX-3100 for Precancerous Cervical Dysplasia (HSIL) - Phase 3 Data

  • ClinicalTrial.gov (NCT03721978): REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)


WHAT IS THE CATALYST EVENT?

  • Phase 3 Data


WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?


PRIOR DATA/EVENTS

PRESS RELEASE

Mechanism of Action

Updated by HC

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See what the community is saying - click to see full post

FDA Decision on Heron's Non-Opioid Pain Med Imminent

SUPN Reports Mixed Results in ADHD

Amp Up July 2018

ASCO 2018 Amp Noteworthy Abstracts

AACR 2018 Amp Up

Cidara Therapeutics: An Attractive Price For A Niche Opportunity With A High Probability Of Success

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon